.jpg)
Dr. Jasmine Cui is the Co-founder, Chairwoman & CEO of InnoCare Pharma Ltd. (InnoCare, HKEX: 09969, SSE: 688428). InnoCare is a commercial stage biotech company committed to discovering, developing, and commercializing innovative drugs for the treatment of cancer and autoimmune diseases. InnoCare has branches in Beijing, Nanjing, Shanghai, Guangzhou, Hangzhou, Hong Kong and Unites States.
Dr. Cui has more than 30 years of experience in drug discovery, development and company management in the pharmaceutical industry. Prior to founding InnoCare, Dr. Cui was the General Manager and Chief Scientific Officer of BioDuro. Before BioDuro, Dr. Cui worked at Merck in the US for 14 years serving as the chair of the early drug development team and other positions.
Dr. Cui received her Ph.D. in molecular biology from Purdue University and completed postdoctoral fellowship at the Howard Hughes Medical Institute affiliated with the University of Michigan. Dr. Cui was the 17th and the 1st female SAPA President.
Dr. Cui has more than 30 years of experience in drug discovery, development and company management in the pharmaceutical industry. Prior to founding InnoCare, Dr. Cui was the General Manager and Chief Scientific Officer of BioDuro. Before BioDuro, Dr. Cui worked at Merck in the US for 14 years serving as the chair of the early drug development team and other positions.
Dr. Cui received her Ph.D. in molecular biology from Purdue University and completed postdoctoral fellowship at the Howard Hughes Medical Institute affiliated with the University of Michigan. Dr. Cui was the 17th and the 1st female SAPA President.
Speaking In
11:00 AM - 12:00 PM
Wednesday, June 7